logo
episode-header-image
Sep 2019
23m 43s

The Past, Present, and Future of Epigene...

Active Motif
About this episode

Joe Fernandez, the founder of Active Motif, has played a significant role in the evolution of the biotechnology industry. He’s seen where the industry has been, and he has a good idea where it’s going. 

Prior to founding Active Motif in 1999, Joe was a co-founder of Invitrogen where he helped revolutionize molecular cloning with the TOPO TA kit. Joe’s passion for disrupting established workflows by making them easier and more efficient didn’t stop there. With Active Motif, he launched the first ever ChIP kit in 2003, and the company now offers the most complete portfolio of ChIP kits for different workflows and sample types, the highest quality ChIP-validated antibodies, and the most comprehensive and most cited end-to-end Epigenetic Services. 

In this interview, we sat down with Joe to learn how he got started in science, what he’s currently excited about, and what he thinks will be the next big thing in epigenetics research.  

 

Contact

 

Up next
Nov 13
Region Capture Micro-C and 3D Genome Structure (Anders Sejr Hansen)
In this episode of the Epigenetics Podcast, we talked with Anders Sejr Hansen from MIT about his work on the impact of 3D genome structures on gene expression, the roles of proteins like CTCF and cohesin, and advanced techniques like Region Capture Micro-C for mapping genome orga ... Show More
1h 3m
Oct 30
Reprogramming Cell Identity through Epigenetic Mechanisms (Vincent Pasque)
In this episode of the Epigenetics Podcast, we talked with Vincent Pasque from KU Leuven about his work on the reprogramming of cell identity through epigenetic mechanisms, particularly during early development and cellular reprogramming. We begin by tracing Vincent's journey int ... Show More
40m 54s
Oct 16
The Impact of Chromatin Architecture on Alzheimer's and Parkinson's Disease (Ryan Corces)
In this episode of the Epigenetics Podcast, we talked with Ryan Corces from the Gladstone Institutes about his work on the impact of chromatin architecture on Alzheimer's and Parkinson's Disease. The discussion begins in discussing he start of Dr. Corces research career and he sh ... Show More
45m 41s
Recommended Episodes
Jul 2025
The AI Pioneer Developing New Kinds of Medicine
Jakob Uszkoreit is the CEO and co-founder of Inceptive, a biotech start-up. He’s also a co-author of “Attention is All You Need,” the paper that created transformer models. Today, transformers power chatbots like ChatGPT and Claude. They’ve also led to breakthroughs in everything ... Show More
47 m
Feb 2025
Jeff Dean & Noam Shazeer — 25 years at Google: from PageRank to AGI
This week I welcome on the show two of the most important technologists ever, in any field.Jeff Dean is Google's Chief Scientist, and through 25 years at the company, has worked on basically the most transformative systems in modern computing: from MapReduce, BigTable, Tensorflow ... Show More
2h 14m
Jul 2025
The Future of Humans, AI and Intelligent Technologies
Dr. Ja-Naé Duane talks about her book, coauthored with futurist Steve Fisher, SuperShifts: Transforming How We Live, Learn, and Work in the Age of Intelligence. Ja-Naé is a leading behavioral scientist, an MIT research fellow, and an innovation strategist with deep expertise in e ... Show More
28m 2s
Aug 21
Evolution designed us to die fast; we can change that — Jacob Kimmel
Jacob Kimmel thinks he can find the transcription factors to reverse aging. We do a deep dive on why this might be plausible and why evolution hasn’t optimized for longevity. We also talk about why drug discovery has been getting exponentially harder, and what a new platform for ... Show More
1h 44m
Aug 2024
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ... Show More
37m 55s
Apr 2025
Breaking Down AI's Role in Genomics and Polygenic Risk Prediction - with Dan Elton of the National Human Genome Research Institute
<p>Today's guest is Dan Elton, a Staff Scientist at the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH). Dan returns to the program to explore how AI is advancing genetic research, from protein engineering to gene editing and risk predi ... Show More
20m 3s
Sep 18
Why experts writing AI evals is creating the fastest-growing companies in history | Brendan Foody (CEO of Mercor)
Brendan Foody is the CEO and co-founder of Mercor, the fastest-growing company in history to go from $1M to $500M in revenue (in just 17 months!). At 22, he is also the youngest American unicorn founder ever. Mercor works with 6 of the Magnificent 7 and all top 5 AI labs to help ... Show More
1h 6m
Jan 2025
Ep515 - Steven Kotler | Decoding the Science of Ultimate Human Performance
<p>As the author of "The Rise of Superman" and co-founder of the Flow Genome Project, Steven Kotler is one of the world's leading experts on ultimate human performance. In this Talk, he provides a tour of the current research focusing on "flow states", or an optimal state of cons ... Show More
1h 12m
Feb 2025
Understanding AI's Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci
<p><span data-preserver-spaces="true">Today's guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is ... Show More
19m 3s